An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect
Por um escritor misterioso
Descrição
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort - Modern Pathology
PDF) An Enhanced Prognostic Score for Overall Survival of Patients with Cancer Derived from a large Real World Cohort
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for
The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - Journal of Cardiac Failure
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score - ScienceDirect
Deep Learning for Predicting Effect of Neoadjuvant Therapies in Non–Small Cell Lung Carcinomas With Histologic Images - Modern Pathology
An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect
External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors - ScienceDirect
Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab - ScienceDirect
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations - The Lancet Haematology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
